Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease

Published:2024-01-11 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Watson Ashleigh¹^ORCID,Karam Lina B¹,Kellermayer Richard¹²^ORCID

Affiliation:

1. Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Texas Children’s Hospital, Baylor College of Medicine , Houston, TX , USA

2. U.S. Department of Agriculture Agricultural Research Service Children’s Nutrition and Research Center , Houston, TX , USA

Funder

Gutsy Kids Fund

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad313/55466257/izad313.pdf

Reference9 articles.

1. Infliximab therapy in pediatric patients 7 years of age and younger;Kelsen;J Pediatr Gastroenterol Nutr.,2014

2. Efficacy of infliximab and adalimumab therapy in very early onset, severe ulcerative colitis;Rohani;Gastroenterol Hepatol Bed Bench,2021

3. Progression to anti-TNF treatment in very early onset inflammatory bowel disease patients;Eindor-Abarbanel;J Pediatr Gastroenterol Nutr.,2022

4. Therapeutic drug monitoring-guided high-dose infliximab for infantile-onset inflammatory bowel disease: a case series;Assa;J Pediatr Gastroenterol Nutr.,2020

5. Validation of predictive models in inflammatory bowel diseases;Kellermayer;Gastroenterology.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP